Sidhdeep Biotech Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 22 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.95 M
- Revenue Growth 13.98%
- Profit Growth -11.98%
- Ebitda 190.25%
- Net Worth 6.57%
- Total Assets -3.90%
About Sidhdeep Biotech
Sidhdeep Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2002 and has a history of 22 years and two months. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.00 M.
The company has closed loans amounting to ₹0.95 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Garg and Mamta Garg serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24231UP2002PTC027069
-
Company No.
027069
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Sidhdeep Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamta Garg
|
Director | 26-Apr-2004 | Current |
|
Mukesh Garg
|
Director | 20-Nov-2002 | Current |
Financial Performance of Sidhdeep Biotech.
Sidhdeep Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.98% increase. The company also saw a substantial fall in profitability, with a 11.98% decrease in profit. The company's net worth moved up by a moderate rise of 6.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidhdeep Biotech?
In 2021, Sidhdeep Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹0.95 M
Charges Breakdown by Lending Institutions
- The Bank Of Maharashtra Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Feb 2009 | The Bank Of Maharashtra Limited | ₹0.95 M | Satisfied |
How Many Employees Work at Sidhdeep Biotech?
Unlock and access historical data on people associated with Sidhdeep Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidhdeep Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidhdeep Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
